A minimally invasive multicancer blood test used with standard-of-care screening is safe, effective, and feasible for use in routine clinical care, according to interim findings from a large, prospective study. The DETECT-A blood test, an early version of the CancerSEEK test currently in development, effectively guided patient management in real time, in some cases leading
0 Comments
This is the sixth story in a series by MedPage Today examining the impact of COVID-19 on vulnerable populations. Past stories reported on the homeless, immigrants in detention, the undocumented, nursing home residents, and incarcerated individuals. With limited national data available to track COVID-19 outcomes by race, states and local municipalities started releasing their own
0 Comments
Kudos, the award-winning service for accelerating research impact, has today announced that it is opening up its leading research communications platform – Kudos Pro – to the global academic community, with complimentary access for 60 days. Over 2,000 researchers around the world have already signed up for complimentary access following an exclusive pre-launch. With campuses
0 Comments
Print this page KENILWORTH, N.J.–(BUSINESS WIRE) April 28, 2020 –Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an additional recommended dosage of 400 mg every six weeks (Q6W) for Keytruda, Merck’s anti-PD-1 therapy, across all adult indications, including monotherapy
0 Comments
QT interval prolongation remained a safety concern with hydroxychloroquine (HCQ) for COVID-19 in reports from Boston and France, highlighting the need for careful monitoring. Risk was particularly elevated when HCQ was administered with azithromycin in both studies, published online in JAMA Cardiology. Both agents have been known to be mechanistically capable of extending the QT
0 Comments
But as some states loosen or let go of their stay-at-home orders, researchers predict a higher death toll from coronavirus this summer than previously expected. By Sunday, more than 1.1 million people in the US have been infected with coronavirus, and more than 66,000 have died, according to data from Johns Hopkins University. States such
0 Comments
Men look at cattle at a stockyard in Lexington, Nebraska, U.S., on Friday, April 24, 2020. Nebraska businesses that have laid off workers during the coronavirus crisis could be forced to repay tax credits and other incentives they have received through the states main business-incentive program, the state Department of Revenue said. Dan Brouillette |
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Here are the coronavirus stories Medscape’s editors around the globe think you need to know about today: Marching (Virtually) for Masks Healthcare professionals led a nationwide “virtual march” today to demand adequate supplies of personal protective equipment (PPE). The organizers of
0 Comments
With the COVID-19 pandemic, non-critical care providers are being asked to assist the critical care community in caring for COVID-19 patients. Although many healthcare systems have been able to handle the burden and ensure the “ideal” care of patients solely by critical care specialists, some systems have been overwhelmed and an “all hands on deck”
0 Comments
Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)–May 1, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivir at
0 Comments
COVID-19 most commonly presents with respiratory symptoms, including cough and shortness of breath, as well as fever. However, digestive symptoms also can occur in patients with COVID-19, and with or without respiratory symptoms. In this Q&A, Dr. Sahil Khanna, a Mayo Clinic gastroenterologist, answers questions about gastrointestinal (GI) symptoms related to COVID-19. Read more: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-expert-explains-gastrointestinal-symptoms-related-to-covid-19/
0 Comments
FDA Approves Darzalex Faspro (daratumumab and hyaluronidase-fihj) for the Treatment of Patients with Multiple Myeloma Print this page HORSHAM, Pa., May 1, 2020 /PRNewswire/ – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approved Darzalex Faspro (daratumumab and hyaluronidase-fihj), a new subcutaneous formulation of daratumumab. Darzalex Faspro™ is approved in four regimens
0 Comments
Per a news release, the Hubble space telescope that has been giving us so many magnificent views of what lies beyond our planet has recently turned 30 years old, having been launched back in 1990. Hubble Celebrates Three Decades Of Operations They weren’t quite aware of it yet, but when the Hubble space telescope launched
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Healthcare professionals helped lead a nationwide “virtual march” today to demand adequate supplies of personal protective equipment (PPE). The most urgent demand, say the event organizers, called Need Masks Today, is for the White House to expand use of the Defense
0 Comments
WASHINGTON — Even as the Trump administration is trying to hand responsibility to states for addressing the COVID-19 pandemic, House and Senate Democrats want laws that would put the federal government more in charge of distributing tests, personal protective equipment (PPE), and other medical supplies to healthcare providers and patients. On Wednesday, the president signaled
0 Comments
But pandemic experts say reopening the country is a “big mistake.” “You’re making a big mistake. It’s going to cost lives,” Dr. Irwin Redlener, a pediatrician and disaster preparedness specialist at Columbia University Medical Center, told CNN on Friday. Redlener and Joseph Fair, a senior fellow in pandemic policy at Texas A&M University, sent a
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) today issued an emergency use authorization (EUA) for remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease. The investigational antiviral drug, manufactured by Gilead Sciences Inc, was
0 Comments
May 1 2020 Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections. Image Credits: royaltystockphoto.com / Shutterstock.com The new antibiotic — administered via the windpipe to target lung infections
0 Comments